Form 4: Bruker CEO Frank Laukien Boosts Stake with $100K Common Stock Purchase

Bruker Corporation's President and CEO, Frank H. Laukien, has increased his direct beneficial ownership in the company by purchasing 2,608 shares of common stock for approximately $100,000.

Summary

• Frank H. Laukien, President & CEO, Director, and 10% Owner of Bruker Corporation (BRKR), purchased 2,608 shares of common stock on June 6, 2025.
• The shares were acquired at a weighted average price of $38.36 per share, with transactions ranging from $38.27 to $38.47.
• This transaction was made pursuant to a Rule 10b5-1 trading plan.
• Following the purchase, Mr. Laukien directly beneficially owns 38,462,171 shares of Common Stock.
• Additionally, Mr. Laukien indirectly beneficially owns 1,046,991 shares through a former spouse, 337,359 shares through a son, 336,607 shares through a daughter, and 273,430 shares as UTMA Custodian for a son, totaling 1,994,387 indirect shares.
• His total beneficial ownership, direct and indirect, amounts to 40,456,558 shares of Bruker Corporation Common Stock.

Sentiment

Score: 8

Explanation: The sentiment is positive due to a significant insider purchase by the CEO, indicating strong confidence in the company's value and future prospects.

Positives

• The purchase of additional shares by the President and CEO signals strong confidence in the company's future prospects and valuation.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned investment strategy by the insider.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Industry Context

This filing is an insider transaction report and does not provide information on broader industry trends or competitive landscape. It reflects an individual executive's investment decision within the life sciences and analytical instrumentation industry.

Corporate Governance

Related Party Transactions

• The document discloses indirect beneficial ownership through a former spouse, son, daughter, and as UTMA Custodian for a son, which are related party holdings. However, the reported transaction itself is an open market purchase, not a related party transaction.

Stakeholder Impact

• Shareholders: The insider purchase may instill greater confidence among existing and potential shareholders, suggesting a positive outlook from company leadership.
• Employees: While not directly impacted, a confident management team can indirectly foster a more stable and positive work environment.

Key Dates

Recommendation

Keywords

Bruker Corporation, BRKR, Frank H. Laukien, Insider Trading, Stock Purchase, SEC Form 4, Beneficial Ownership, CEO Stock Purchase, Rule 10b5-1